INTRODUCTIONThe popularity of surgical butt lifting, and augmenting procedures is rapidly growing. Since 2015, the number of performed procedures increased on average by 25% each year,1 while the increase over…
Read More
INTRODUCTIONDISCLOSURESREFERENCES Bolognia, Jean, Joseph L. Jorizzo, and Julie V. Schaffer. Dermatology. Philadelphia: Elsevier Saunders, 2012. Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol. 2010; 11(10):983-91…
Read More
Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation
INTRODUCTIONWe investigated a subtype of Telogen Effluvium associated with Dysesthesia, (TED) which was defined as the presence of Telogen Effluvium with severe itch, pain, soreness, burning, or formication in the…
Read More
INTRODUCTIONNon-melanoma skin cancer (NMSC) is the most commonly diagnosed cancer in the United States.1,2 While the prevalence of NMSC is continually elevating the overall treatment of choice remains to be…
Read More
INTRODUCTIONGoogle Search is an important tool for patients researching skin care treatments and finding dermatologists. Data from the 3 billion daily Google searches1 can be used to trend epidemiological patterns…
Read More
For more practice Q&A and Board prep study tools—visit DermInReview.comCase Studies authored by our educational partner GW School of Medicine and Health Sciences Dermatology Residency Program1) A 67-year-old African American male…
Read More
Cutera Launches truSculpt® iD, Personalized Body Sculpting: The Next Evolution Cutera Inc., a leading provider of laser, light, and other energy-based aesthetic systems for practitioners worldwide, today announces the availability…
Read More
BACKGROUNDMSC still remains the most common cancer in the United States,4 with its incidence increasing in both men and women under the age of 40. There is an estimated 3.5…
Read More
INTRODUCTIONThe cannabis plant, cannabis sativa, and its derivatives have been used in medicinal preparations for millennia to treat pain, nausea, and epilepsy. Recent research has identified a number of other…
Read More
INTRODUCTIONPsoriasis is a chronic and persistent, immune-mediated disease that affects approximately 2% of the population 1-3. Most patients have mild to moderate plaque psoriasis, which despite its limited cutaneous involvement,…
Read More
INTRODUCTIONPsoriasis is a common chronic inflammatory disease as- sociated with numerous comorbidities, with a profound impact on patients’ quality of life. Assessing disease severity without biomarkers has led to the…
Read More
INTRODUCTIONPsoriasis (PsO) is a chronic immune-mediated skin disorder characterized by erythematous, scaling plaques, which are often pruritic or painful. The prevalence of PsO in the United States is approximately 3.2%…
Read More





